Search details
1.
Iran in transition.
Lancet
; 393(10184): 1984-2005, 2019 05 11.
Article
in English
| MEDLINE | ID: mdl-31043324
2.
Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran.
Med J Islam Repub Iran
; 29: 260, 2015.
Article
in English
| MEDLINE | ID: mdl-26793651
3.
The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies.
Heliyon
; 9(3): e14108, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36873499
4.
Exploring the clinical benefit of ventilation therapy across various patient groups with COVID-19 using real-world data.
Sci Rep
; 13(1): 10747, 2023 07 03.
Article
in English
| MEDLINE | ID: mdl-37400560
5.
Assessment of BIV1-CovIran inactivated vaccine-elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern.
Clin Microbiol Infect
; 28(6): 882.e1-882.e7, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35248745
6.
National and Subnational Patterns of Cause of Death in Iran 1990-2015: Applied Methods.
Arch Iran Med
; 20(1): 2-11, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-28112524
7.
Prevention by L-arginine/nitric oxide of chlordiazepoxide-induced toxic reactions in the rat salivary gland.
Toxicol Mech Methods
; 16(6): 331-7, 2006.
Article
in English
| MEDLINE | ID: mdl-20021032
8.
Birth seasonality in rural areas of Iran, analysis of 5,536,262 births from 1992 to 2007.
Ann Epidemiol
; 26(12): 846-852.e3, 2016 12.
Article
in English
| MEDLINE | ID: mdl-28340910
9.
Burden of Cancers in Iran from 1990 to 2010: findings from the Global Burden of Disease study 2010.
Arch Iran Med
; 18(10): 629-37, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26443246
10.
The Most Prevalent Causes of Deaths, DALYs, and Geriatric Syndromes in Iranian Elderly People Between 1990 and 2010: findings from the Global Burden of Disease study 2010.
Arch Iran Med
; 18(8): 462-79, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26265514
11.
Tobacco Smoking Status and the Contribution to Burden of Diseases in Iran, 1990-2010: findings from the Global Burden of Disease Study 2010.
Arch Iran Med
; 18(8): 493-501, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26265517
12.
Burden of Hepatitis C in Iran Between 1990 and 2010: findings from the Global Burden of Disease Study 2010.
Arch Iran Med
; 18(8): 508-14, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26265519
13.
Burden of Drug and Alcohol Use Disorders in Iran: findings from the Global Burden of Disease Study 2010.
Arch Iran Med
; 18(8): 480-5, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26265515
14.
"Budget impact analyses": a practical policy making tool for drug reimbursement decisions.
Iran J Pharm Res
; 13(3): 1105-9, 2014.
Article
in English
| MEDLINE | ID: mdl-25276214
15.
Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran.
Iran J Pharm Res
; 13(Suppl): 225-34, 2014.
Article
in English
| MEDLINE | ID: mdl-24711850
16.
NASBOD 2013: design, definitions, and metrics.
Arch Iran Med
; 17(1): 7-15, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24444059
17.
National and sub-national burden of breast cancer in Iran; 1990-2013.
Arch Iran Med
; 17(12): 794-9, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25481316
18.
National and sub-national prevalence, trend, and burden of end stage renal diseases (ESRD) in Iran 1990-2013; the study protocol.
Arch Iran Med
; 17(12): 800-3, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25481317
19.
Costs of Treatment after Renal Transplantation: Is it Worth to Pay More?
Iran J Pharm Res
; 13(1): 271-8, 2014.
Article
in English
| MEDLINE | ID: mdl-24734080
20.
National and sub-national prevalence, trend, and burden of metabolic risk factors (MRFs) in Iran: 1990 - 2013, study protocol.
Arch Iran Med
; 17(1): 54-61, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24444064